1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow dactolisib: new trials by email Literature Review of dactolisib trials Research Report on dactolisib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy. BEZ235 (Stage 1) - Pancreatic Neuroendocrine Tumors (pNET) | Phase 2 | Completed | Novartis Pharmaceuticals | 31 | 2012-11-01 | 2016-05-02 |
Neuroectodermal Tumors, Primitive (1)
Austria (1) · Belgium (1) · France (1) · Germany (1) · Italy (1) · Netherlands (1) · Spain (1) · United Kingdom (1) · United States (1)